Intravenous immunoglobulin in toxic epidermal necrolysis [7]

International Journal of Dermatology

Volumn 45, Issue 9, 2006, Pages 1117-1118

  Pasic, Srdjan ^a  

^a Mother and Child Health Institute   (Yugoslavia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; IBUPROFEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; SULFONAMIDE;

ADOLESCENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE REGIMEN; EYE DISEASE; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE; LETTER; MALE; PROTEIN DEGRADATION; STEVENS JOHNSON SYNDROME; SURVIVAL RATE; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME;

CHILD; CHILD, PRESCHOOL; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; TREATMENT OUTCOME;

EID: 33748262063     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02833.x     Document Type: Letter

References (4)

1. Al-Mutairi N, Arun J, Osama N-E, et al. Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis. Int J Dermatol 2004; 43: 847-851.
2. Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol 1993; 129: 92-96.
3. Metry DW, Jung P, Levy ML. Use of intravenous immunoglobulin in children with Stevens-Johnson syndrome and toxic epidermal necrolysis: Seven cases and review of literature. Pediatrics 2003; 112: 1430-1436.
4. Princ C, Kerdel FA, Padilla SR, et al. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulin. Arch Dermatol 2003; 139: 26-32.